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Abstract: Concepts of disease severity, activity, control and responsiveness to treatment are linked but
different. Severity refers to the loss of function of the organs induced by the disease process or to the oc-
currence of severe acute exacerbations. Severity may vary over time and needs regular follow-up. Control
is the degree to which therapy goals are currently met. These concepts have evolved over time for asthma
in guidelines, task forces or consensus meetings. The aim of this paper is to generalize the approach of
the uniform definition of severe asthma presented to WHO for chronic allergic and associated diseases
(rhinitis, chronic rhinosinusitis, chronic urticaria and atopic dermatitis) in order to have a uniform def-
inition of severity, control and risk, usable in most situations. It is based on the appropriate diagnosis,
availability and accessibility of treatments, treatment responsiveness and associated factors such as co-
morbidities and risk factors. This uniform definition will allow a better definition of the phenotypes of
severe allergic (and related) diseases for clinical practice, research (including epidemiology), public health
purposes, education and the discovery of novel therapies
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